AdvanSix Inc. — 2017 Form 10-K Summary
Reporting period: Fiscal year ended December 31, 2017; selected fourth-quarter results are also summarized. AdvanSix is an integrated U.S. manufacturer of Nylon 6, caprolactam, ammonium sulfate fertilizer and chemical intermediates. It was spun off from Honeywell on October 1, 2016, so some prior-period costs and results reflect its former relationship with Honeywell.
Financial performance and condition
| Metric | FY 2017 | FY 2016 |
|---|---|---|
| Sales | $1,475.2 million | $1,191.5 million |
| Gross profit / gross margin | $226.2 million / 15.3% | $107.6 million / 9.0% |
| Net income | $146.7 million | $34.1 million |
| Diluted EPS | $4.72 | $1.12 |
| Operating cash flow | $134.6 million | $113.7 million |
| Capital expenditures | $86.4 million | $84.0 million |
| EBITDA margin (non-GAAP) | 13.6% | 8.1% |
Sales rose 23.8% year over year, reflecting higher prices (15.3%) and volume (8.5%). Higher raw-material pass-through prices and improved market pricing lifted sales; improved production and the absence of the 2016 fourth-quarter outages supported volumes. Gross margin expanded with higher sales and production volumes. EBITDA was $200.8 million in 2017; 2016 EBITDA included a $15.5 million one-time supply-agreement termination benefit.
Reported 2017 net income included a $53.4 million one-time tax benefit from the Tax Cuts and Jobs Act, which reduced the federal corporate rate from 35% to 21%. Excluding that benefit, the company reported net income of $93.3 million and diluted EPS of $3.00. The reported effective tax rate was negative 1.4%; management expected an approximately 25% effective tax rate for 2018, subject to further analysis of the tax law.
Fourth-quarter 2017 sales were $370.4 million, gross profit $44.6 million and net income $72.4 million, including the tax-law benefit. In fourth-quarter 2016, the company reported a $20.1 million gross loss and a $24.7 million net loss, associated with extended and unplanned plant outages.
At year-end, cash and cash equivalents were $55.4 million; current assets were $387.8 million and current liabilities $296.8 million. Total debt was $265.2 million, with $16.9 million classified as current. Operating cash flow less capital expenditures was approximately $48.2 million (derived). The company reported $153.7 million available under its credit agreement and compliance with its covenants at December 31, 2017.
Material changes versus the prior comparable period
- Annual sales increased 23.8%, net income rose from $34.1 million to $146.7 million, and gross margin improved from 9.0% to 15.3%.
- Operating cash flow increased by $20.9 million; higher earnings were partly offset by increased receivables and other working-capital movements.
- SG&A increased 35% to $72.8 million, primarily reflecting costs of operating as an independent public company, including workforce and infrastructure costs.
- Debt-related non-operating expense increased as the company incurred a full year of interest expense in 2017, versus only the fourth quarter in 2016.
- The product mix shifted: fertilizer fell to 19% of sales from 24%, while chemical intermediates rose to 33% from 31% and caprolactam to 19% from 17%.
Outlook, commentary, risks and unusual items
- Outlook: Management expected 2018 capital expenditures of approximately $110–$120 million, including $20–$30 million for growth and cost-saving projects. It expected an effective tax rate of approximately 25% and described agriculture fundamentals as challenging through the 2018 planting season. No specific sales or earnings guidance was provided.
- Subsequent production disruption: Severe winter weather caused a temporary Hopewell facility issue in January 2018, reducing caprolactam and resin production. Management estimated an approximately $30 million unfavorable pre-tax impact in first-quarter 2018 from fixed-cost absorption, lost sales, maintenance and incremental raw-material costs; the event did not affect fourth-quarter 2017 results.
- Debt refinancing after year-end: On February 21, 2018, the company replaced its $270 million term loan and $155 million revolver with a $425 million revolving facility, borrowed $242 million to repay the term loan, and extended maturity to February 2023. The filing states $181.7 million was available under the amended facility as of that date.
- Operating and market risks: Nylon and caprolactam markets are cyclical and exposed to global oversupply, competition and raw-material price volatility. The integrated production chain also makes unplanned outages at any major site a risk to downstream production. Cumene, natural gas and sulfur are key inputs.
- Concentration and contingencies: The ten largest customers represented about 44% of sales; Shaw Industries accounted for 22% and is the largest customer. A potential EPA penalty matter concerning alleged Hopewell permit violations remained under discussion; the company did not expect a material adverse effect. Environmental consent decrees require corrective work at Hopewell on schedules extending through 2018 and 2019.
- Other obligations: The company contributed $16.8 million to its defined benefit pension plan in 2017 and expected 2018 contributions of approximately $8–$10 million. The 2017 tax-law accounting was provisional and could be adjusted during 2018.
Most important facts for investors to verify
- Whether the estimated $30 million first-quarter 2018 weather-related impact and production recovery matched subsequent reported results.
- How much 2017 earnings growth was sustainable operating improvement versus the $53.4 million one-time tax benefit; confirm the eventual tax accounting and effective rate.
- Actual liquidity, borrowing costs, covenant headroom and debt balances under the February 2018 amended credit agreement.
- Whether improved industry spreads and production volumes persisted, and whether customer concentration—especially Shaw’s 22% share of sales—changed.
- Progress and costs related to Hopewell environmental obligations, the EPA matter, planned capital spending and pension funding.